We are live on ! Find out more
SLNO

Soleno Therapeutics
SLNO

Delisted

SLNO was delisted on the 15th of May, 2026.

Back to rankings

0 hedge funds and large institutions have $0 invested in Soleno Therapeutics in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 220 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 225 → 0 (-225)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $2.08B → $0 (-$2.08B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 220

120.6% less ownership

Funds ownership: 120.6% → 0% (-121%)

Holders
–
Holders Change
-225
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
220
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$194M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$148M
3
BlackRock
BlackRock
New York
-$125M
4
State Street
State Street
Massachusetts
-$89.8M
5
ACA
Avoro Capital Advisors
New York
-$77M
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
– -$18.4M -549,877 Closed
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
– -$16.2M -483,884 Closed
Vanguard Portfolio Management
28
Vanguard Portfolio Management
Pennsylvania
– -$16M -477,321 Closed
Renaissance Technologies
29
Renaissance Technologies
New York
– -$15M -447,300 Closed
Bank of America
30
Bank of America
North Carolina
– -$14.7M -439,902 Closed
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
– -$14.5M -432,535 Closed
CM
32
Caption Management
Oklahoma
– -$14.1M -420,143 Closed
Charles Schwab
33
Charles Schwab
California
– -$13.6M -405,910 Closed
Northern Trust
34
Northern Trust
Illinois
– -$13.2M -393,523 Closed
Citadel Advisors
35
Citadel Advisors
Florida
– -$12.9M -386,545 Closed
Goldman Sachs
36
Goldman Sachs
New York
– -$12.9M -385,798 Closed
IC
37
Ikarian Capital
Texas
– -$11.5M -344,123 Closed
Vanguard Fiduciary Trust
38
Vanguard Fiduciary Trust
Pennsylvania
– -$11.5M -342,758 Closed
IHAM
39
Integral Health Asset Management
New York
– -$10.9M -325,000 Closed
VC
40
Vivo Capital
California
– -$9.87M -294,909 Closed
Aberdeen Group
41
Aberdeen Group
United Kingdom
– -$9.62M -287,456 Closed
CS
42
Candriam SCA
Luxembourg
– -$9.43M -281,620 Closed
Bank of New York Mellon
43
Bank of New York Mellon
New York
– -$9.3M -277,851 Closed
EA
44
Emerald Advisers
Pennsylvania
– -$9.18M -274,138 Closed
PCM
45
Penn Capital Management
Pennsylvania
– -$9.02M -268,785 Closed
RSCM
46
Rock Springs Capital Management
Maryland
– -$8.61M -257,253 Closed
LGM
47
Logos Global Management
California
– -$8.37M -250,000 Closed
PHS
48
PFM Health Sciences
California
– -$8.31M -248,180 Closed
Morgan Stanley
49
Morgan Stanley
New York
– -$8.11M -242,262 Closed
UBS Group
50
UBS Group
Switzerland
– -$7.54M -225,147 Closed
1
2
3 4 5

SLNO Hedge Fund Activity: Q2 2026 in Review

0 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Soleno Therapeutics (SLNO) for Q2 2026, worth a combined $0 — down 100% from $2.08B a quarter earlier.

Sellers outnumbered buyers: 220 funds closed out of SLNO and 0 opened new positions — a net loss of 220 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $194M sold.

  • 0 institutional investors held Soleno Therapeutics (SLNO) as of Q2 2026, down from 225 in Q1 2026.
  • Funds reported $0 of Soleno Therapeutics stock for Q2 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Soleno Therapeutics positions in Q2 2026 and 220 closed out, a net change of -220 holders.
  • The largest Soleno Therapeutics seller in Q2 2026 was Fidelity Investments, an estimated $194M sold.

Based on aggregated 13F filings for Q2 2026.